Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation

Clinical trial NCT02867384 · COMPLETED

Trial details

NCT number: NCT02867384
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft vs. Host Disease

Start date: 2016-11-29
Primary completion: 2023-11-29
Enrollment: 181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.